US court prevents Dr Reddy's from launching opioid treatment drug Suboxone

The preliminary injunction orders issued on Friday by a US court against Dr Reddy's Laboratories Limited on the launch of generic Suboxone, a sublingual film product indicated for treatment of opioid dependence, comes as a set back for the company.

This preliminary injunction was followed after the District Court of the District of New Jersey issued a temporary restraining order on June 16 against further sale and commercialisation of generic Suboxone by Dr Reddy's in the US.

With sales of around $1.86 billion annually, Suboxone was one of the key near-term launches lined up by Dr Reddy's this year with